1. Home
  2. CTKB vs DNA Comparison

CTKB vs DNA Comparison

Compare CTKB & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$5.37

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$10.24

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
DNA
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
652.1M
562.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CTKB
DNA
Price
$5.37
$10.24
Analyst Decision
Hold
Hold
Analyst Count
5
2
Target Price
$5.70
$10.50
AVG Volume (30 Days)
785.4K
886.1K
Earning Date
02-26-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$196,828,000.00
$180,606,000.00
Revenue This Year
$0.08
N/A
Revenue Next Year
$5.45
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.37
$5.00
52 Week High
$6.18
$17.58

Technical Indicators

Market Signals
Indicator
CTKB
DNA
Relative Strength Index (RSI) 51.55 59.42
Support Level $5.21 $8.82
Resistance Level $5.70 $11.10
Average True Range (ATR) 0.26 0.62
MACD -0.01 0.15
Stochastic Oscillator 38.64 70.44

Price Performance

Historical Comparison
CTKB
DNA

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: